London Esketamine Clinic

London Esketamine Clinic takes great pride in being the first private medical clinic and entity in the UK to offer Esketamine nasal spray to patients, starting from September 2020.

Operating under the umbrella of Nurify Medical, the London Esketamine Clinic extends its services with dedication.

In 2020, the Medical and Healthcare Products Regulatory Agency (MHRA) in the UK granted approval to Esketamine (Spravato®) as a viable treatment for patients dealing with moderate to severe treatment-resistant depression.

This form of depression, often categorized by an unresponsiveness to two different antidepressants, finds a potential solution in Esketamine.

Our team of expert consultant psychiatrists will guide you through an assessment process to confirm your diagnosis, determining whether Esketamine is the optimal course of treatment.

Esketamine is administered through a nasal spray device, ensuring ease of use.

However, it’s important to note that this treatment is exclusively administered within our clinic, under the vigilant supervision of our skilled clinicians.